Clinical Trial Update: DP-b99 in the Treatment of Acute High-risk Pancreatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of DP-b99 for acute high-risk pancreatitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• DP-b99 (DP-b99)

Snippet

Sponsor: D-Pharm Ltd. | Conditions: Pancreatitis | Phase 2 | Status: TERMINATED